These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2977981

  • 21. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM.
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [Abstract] [Full Text] [Related]

  • 22. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 23. Mesoglycan in treatment of patients with cerebral ischemia: effects on hemorheologic and hematochemical parameters.
    Vecchio F, Zanchin G, Maggioni F, Santambrogio C, De Zanche L.
    Acta Neurol (Napoli); 1993 Dec; 15(6):449-56. PubMed ID: 8160557
    [Abstract] [Full Text] [Related]

  • 24. Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers. A placebo-controlled study with an enteric-coated formulation.
    Mauro M, Palmieri GC, Palazzini E, Barbanti M, Calanni Rindina F, Milani MR.
    Curr Med Res Opin; 1993 Dec; 13(2):87-95. PubMed ID: 8325046
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan.
    Viliani T, Scarselli M, Pieri A, Gatti M, Santini M, Pasquetti P.
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):21-9. PubMed ID: 19270639
    [Abstract] [Full Text] [Related]

  • 26. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications].
    Petruzzellis V, Velon A.
    Minerva Med; 1985 Mar 24; 76(12):543-8. PubMed ID: 3157887
    [Abstract] [Full Text] [Related]

  • 27. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
    van Giezen JJ, Chung-A-Hing JE, Vegter CB, Bouma BN, Jansen JW.
    Thromb Haemost; 1994 Dec 24; 72(6):887-92. PubMed ID: 7740459
    [Abstract] [Full Text] [Related]

  • 28. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2008 Dec 24; 121(6):787-91. PubMed ID: 17869326
    [Abstract] [Full Text] [Related]

  • 29. Pharmacodynamics and pharmacokinetics of Veliten (rutine, alpha-tocopherol and ascorbic acid) in patients with chronic venous insufficiency.
    Auteri A, Pasqui AL, Bruni F, Di Renzo M, Bova G, Chiarion C, Delchambre J.
    Int J Clin Pharmacol Res; 1994 Dec 24; 14(3):95-100. PubMed ID: 7883390
    [Abstract] [Full Text] [Related]

  • 30. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Dec 24; 425():1-272. PubMed ID: 12616286
    [Abstract] [Full Text] [Related]

  • 31. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1987 Nov 24; 323():1-172. PubMed ID: 12748730
    [Abstract] [Full Text] [Related]

  • 32. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb 24; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

  • 33. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan 24; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 34. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1998 Aug 24; 473():1-326. PubMed ID: 12571677
    [Abstract] [Full Text] [Related]

  • 35. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 24; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 36. Coagulation and fibrinolysis in rats poisoned with mercuric chloride.
    Michalska M, Mirowski M, Wierzbicki R.
    Pol J Pharmacol Pharm; 1988 Feb 24; 40(4):365-71. PubMed ID: 3146750
    [Abstract] [Full Text] [Related]

  • 37. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
    Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH.
    J Lab Clin Med; 1994 Feb 24; 123(2):232-40. PubMed ID: 8301199
    [Abstract] [Full Text] [Related]

  • 38. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Feb 24; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 39. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Feb 24; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 40. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 24; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.